Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Los Tres Paso Trial
NCT03389477Phase 2Active, not recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2018
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in head and neck squamous cell carcinoma (HNSCC), sponsored by Washington University School of Medicine. Started Apr 2018; status: active, not recruiting.
02
Drugs
palbociclib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT03389477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03389477.